Cannabis Bioscience International Holdings, Inc. (CBIH)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
0.00 (-3.85%)
Dec 24, 2024, 4:00 PM EST
CBIH Revenue
Cannabis Bioscience International Holdings had revenue of $178.89K in the quarter ending August 31, 2024, with 145.65% growth. This brings the company's revenue in the last twelve months to $354.91K, up 44.33% year-over-year. In the fiscal year ending May 31, 2024, Cannabis Bioscience International Holdings had annual revenue of $248.84K, down -21.46%.
Revenue (ttm)
354.91K
Revenue Growth
+44.33%
P/S Ratio
18.38
Revenue / Employee
177.45K
Employees
2
Market Cap
6.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2024 | 248.84K | -67.98K | -21.46% |
| May 31, 2023 | 316.83K | 101.85K | 47.37% |
| May 31, 2022 | 214.98K | -546.76K | -71.78% |
| May 31, 2021 | 761.74K | 471.50K | 162.46% |
| May 31, 2020 | 290.23K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Ryman Healthcare Limited | 458.44M |
| Elekta AB (publ) | 1.66B |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Cannabis Bioscience International Holdings News
- 7 weeks ago - CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy - Newsfile Corp
- 2 months ago - CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings - Newsfile Corp
- 5 months ago - CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications - GlobeNewsWire
- 6 months ago - CBIH Charts Path to Future Leadership in Cannabis Medicine - GlobeNewsWire
- 6 months ago - CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine - Newsfile Corp
- 6 months ago - CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments - Newsfile Corp
- 6 months ago - CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change - GlobeNewsWire
- 6 months ago - CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader - Newsfile Corp